NR2F6 and breast cancer: Nuclear receptor subfamily 2 group F member 6 (NR2F6) could transcriptionally activate ACAT1 and enhance the suppressive role of ACAT1-induced METTL3 acetylation on cell migration and invasion of breast cancer (54).